Kyntra Bio (KYNB) Assets Average (2016 - 2025)
Historic Assets Average for Kyntra Bio (KYNB) over the last 11 years, with Q3 2025 value amounting to $157.5 million.
- Kyntra Bio's Assets Average fell 4349.79% to $157.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.5 million, marking a year-over-year decrease of 4349.79%. This contributed to the annual value of $319.0 million for FY2024, which is 3826.97% down from last year.
- Kyntra Bio's Assets Average amounted to $157.5 million in Q3 2025, which was down 4349.79% from $171.6 million recorded in Q2 2025.
- In the past 5 years, Kyntra Bio's Assets Average registered a high of $829.6 million during Q3 2021, and its lowest value of $157.5 million during Q3 2025.
- Moreover, its 5-year median value for Assets Average was $526.8 million (2023), whereas its average is $514.4 million.
- Per our database at Business Quant, Kyntra Bio's Assets Average skyrocketed by 243.46% in 2021 and then crashed by 5189.52% in 2025.
- Kyntra Bio's Assets Average (Quarter) stood at $812.2 million in 2021, then dropped by 24.96% to $609.5 million in 2022, then decreased by 27.48% to $442.0 million in 2023, then tumbled by 45.82% to $239.5 million in 2024, then tumbled by 34.22% to $157.5 million in 2025.
- Its Assets Average stands at $157.5 million for Q3 2025, versus $171.6 million for Q2 2025 and $189.9 million for Q1 2025.